Atlas Venture Associates IX, LLC — Intellia Therapeutics, Inc. insider: 17 transactions · InsiderLens

Atlas Venture Associates IX, LLC — Intellia Therapeutics, Inc. insider: 17 transactions · InsiderLens

Empresa	Notificado	Tipo	Cant.	Precio	Valor · USD	Fuente	Detalle
Surface Oncology, Inc.	Dec 21, 2020	Venta	-1,700,000	8.10 USD	$13.8M	SEC
Surface Oncology, Inc.	Apr 23, 2018	Otro	3,181,817	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	OtroD (derivado)	-7,000,000	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Compra	100,000	15.00 USD	$1.5M	SEC
Cogent Biosciences, Inc.	Apr 3, 2018	Otro	3,184,446	—	—	SEC
Cogent Biosciences, Inc.	Apr 3, 2018	OtroD (derivado)	-83,037	0.00 USD	—	SEC
Cogent Biosciences, Inc.	Apr 3, 2018	Compra	94,052	12.00 USD	$1.1M	SEC
Cogent Biosciences, Inc.	Apr 3, 2018	OtroD (derivado)	-3,184,446	0.00 USD	—	SEC
Cogent Biosciences, Inc.	Apr 3, 2018	Otro	83,037	—	—	SEC
Intellia Therapeutics, Inc.	May 11, 2016	OtroD (derivado)	-3,809,524	0.00 USD	—	SEC
Intellia Therapeutics, Inc.	May 11, 2016	Otro	2,463,201	—	—	SEC
Intellia Therapeutics, Inc.	May 11, 2016	Otro	492,640	—	—	SEC
Intellia Therapeutics, Inc.	May 11, 2016	OtroD (derivado)	-946,237	0.00 USD	—	SEC
Intellia Therapeutics, Inc.	May 11, 2016	OtroD (derivado)	-761,905	0.00 USD	—	SEC
Intellia Therapeutics, Inc.	May 11, 2016	OtroD (derivado)	-1,333,333	0.00 USD	—	SEC
Intellia Therapeutics, Inc.	May 11, 2016	Otro	611,827	—	—	SEC
Intellia Therapeutics, Inc.	May 11, 2016	Otro	862,120	—	—	SEC